HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,428,680 | +2.9% | 37,400 | -2.9% | 0.03% | +6.5% |
| Q2 2023 | $1,388,695 | +1.3% | 38,500 | +7.2% | 0.03% | -11.4% |
| Q1 2023 | $1,371,021 | +66454.4% | 35,900 | -0.8% | 0.04% | -37.5% |
| Q4 2022 | $2,060 | -99.9% | 36,200 | -1.4% | 0.06% | +33.3% |
| Q3 2022 | $1,451,000 | -19.9% | 36,700 | +1.4% | 0.04% | -12.5% |
| Q2 2022 | $1,812,000 | +13.4% | 36,200 | -1.9% | 0.05% | +26.3% |
| Q1 2022 | $1,598,000 | +9.8% | 36,900 | +1.9% | 0.04% | +18.8% |
| Q4 2021 | $1,456,000 | -1.4% | 36,200 | -0.3% | 0.03% | -11.1% |
| Q3 2021 | $1,477,000 | -6.3% | 36,300 | +4.6% | 0.04% | -5.3% |
| Q2 2021 | $1,576,000 | +14.5% | 34,700 | +5.2% | 0.04% | +5.6% |
| Q1 2021 | $1,376,000 | +1.3% | 33,000 | +3.8% | 0.04% | -7.7% |
| Q4 2020 | $1,358,000 | – | 31,800 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 14,092,771 | $256,066,000 | 16.64% |
| BB BIOTECH AG | 8,247,860 | $149,864,000 | 3.97% |
| MSD Partners, L.P. | 2,245,000 | $40,792,000 | 3.07% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 428,633 | $5,969,000 | 2.84% |
| First Light Asset Management, LLC | 885,523 | $16,090,000 | 2.60% |
| SNYDER CAPITAL MANAGEMENT L P | 2,387,350 | $43,378,000 | 1.93% |
| Sterling Global Strategies LLC | 22,000 | $400,000 | 1.74% |
| Taylor Wealth Management Partners | 221,380 | $4,022,000 | 1.71% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,228,399 | $167,680,000 | 1.68% |
| DOHENY ASSET MANAGEMENT /CA | 124,393 | $2,260,000 | 1.18% |